Trial intelligence / Profile preview

Radiotherapy versus chemoradiotherapy for palliation of dysphagia in advanced oesophageal cancer

2005-003755-12Phase 4Completed

Sponsor
Hull University Teaching Hospitals
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of cisplatin and fluorouracil in esophageal cancer (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Relief of dysphagia (primary). Started Nov 2005; status: completed.

02

Drugs

cisplatinfluorouracil
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on 2005-003755-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003755-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call